Sepsis is a severe illness characterized by a systemic, whole-body response to infection and is a frequent cause of morbidity and mortality in hospitalized patients. Early differentiation of sepsis from systemic inflammatory response syndrome (SIRS) is imperative for appropriate therapy.
| Test Name and Number | Recommended Use | Limitations | Follow Up |
|---|---|---|---|
| CBC with Platelet Count and Automated Differential 0040003 Method: Automated Cell Count/Differential |
Initial testing to help differentiate bacterial from viral etiology |
||
| Blood Culture 0060102 Method: Continuous Monitoring Blood Culture/Identification |
Evaluate for presence of bacteremia |
Testing is limited to the University of Utah Health Sciences Center Typically requires ≥2 sites |
|
| Wound Culture and Gram Stain 0060132 Method: Stain/Culture/Identification |
Identify causative organism of infected site(s) | ||
| Cerebrospinal Fluid (CSF) Culture and Gram Stain 0060106 Method: Stain/Culture/Identification |
Identify cause of CNS infection |
||
| Electrolyte Panel 0020410 Method: Quantitative Ion-Selective Electrode/Enzymatic |
Evaluate presence of organ dysfunction Panel includes anion gap carbon dioxide, chloride, potassium, and sodium |
||
| Renal Function Panel 0020144 Method: Quantitative Chemiluminescent Immunoassay/Quantitative Enzyme-Linked Immunosorbent Assay |
Evaluate presence of renal dysfunction Panel includes albumin, calcium, carbon dioxide, creatinine, chloride, glucose, phosphorous, potassium, sodium, and urea nitrogen |
||
| Hepatic Function Panel 0020416 Method: Quantitative Enzymatic/Quantitative Spectrophotometry |
Evaluate presence of hepatic dysfunction Panel includes albumin; ALP; AST; ALT; bilirubin, direct; protein, total; and bilirubin, total |
||
| C-Reactive Protein 0050180 Method: Quantitative Immunoturbidimetry |
May be a helpful in evaluating sepsis, particularly neonatal sepsis |
Normal CRP does not rule out sepsis Does not peak for ≥48 hours after infection starts Does not differentiate between sepsis and SIRS |
|
| Cell Count, Body Fluid 0095019 Method: Cell Count/Differential |
Test of choice for differential diagnosis on synovial fluid aspirate | ||
| Procalcitonin 0020763 Method: Immunofluorescence |
Proposed at this time as an early marker (<24 hours) for sepsis, particularly in the newborn |
May not be elevated in severe local infection May be elevated in other conditions such as burns, trauma, and extensive surgery Does not differentiate between sepsis and SIRS |